Atlas Trials

Effect of Rifampin on the Pharmacokinetics of BAY73-4506

Clinical trial NCT01322438 · COMPLETED

Trial details

NCT number
NCT01322438
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2011-03-01
Primary completion
2011-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.